- Home
- MGLD vs INCR Comparison
MGLD vs INCR Comparison
Compare MGLD & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGLD
- INCR
- Stock Information
- Founded
- MGLD 1996
- INCR 1994
- Country
- MGLD United States
- INCR Israel
- Employees
- MGLD N/A
- INCR N/A
- Industry
- MGLD Finance/Investors Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- MGLD Finance
- INCR Health Care
- Exchange
- MGLD Nasdaq
- INCR Nasdaq
- Market Cap
- MGLD 59.9M
- INCR 65.3M
- IPO Year
- MGLD N/A
- INCR N/A
- Fundamental
- Price
- MGLD $1.50
- INCR $1.46
- Analyst Decision
- MGLD
- INCR
- Analyst Count
- MGLD 0
- INCR 0
- Target Price
- MGLD N/A
- INCR N/A
- AVG Volume (30 Days)
- MGLD 11.1K
- INCR 29.1K
- Earning Date
- MGLD 02-12-2025
- INCR 12-31-2024
- Dividend Yield
- MGLD N/A
- INCR N/A
- EPS Growth
- MGLD N/A
- INCR N/A
- EPS
- MGLD N/A
- INCR N/A
- Revenue
- MGLD $32,511,000.00
- INCR $72,420,918.00
- Revenue This Year
- MGLD N/A
- INCR N/A
- Revenue Next Year
- MGLD N/A
- INCR $39.30
- P/E Ratio
- MGLD N/A
- INCR N/A
- Revenue Growth
- MGLD N/A
- INCR N/A
- 52 Week Low
- MGLD $0.78
- INCR $1.17
- 52 Week High
- MGLD $1.92
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- MGLD 54.48
- INCR 52.10
- Support Level
- MGLD $1.32
- INCR $1.30
- Resistance Level
- MGLD $1.58
- INCR $1.47
- Average True Range (ATR)
- MGLD 0.13
- INCR 0.05
- MACD
- MGLD 0.01
- INCR 0.02
- Stochastic Oscillator
- MGLD 75.42
- INCR 88.83
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.